Position in GRAL
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$593,675
New position
Shares Held
8,696
first reported quarter
Ownership
0.019%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#141
of 373 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026HARBOR CAPITAL ADVISORS, INC. holds $22,849,574 across 11 Diagnostics & Research names. GRAL ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDNT |
RadNet, Inc.
|
116,506 | $7,184,925 | |
| 2 | TWST |
Twist Bioscience Corp
|
53,282 | $5,481,652 | |
| 3 | NEO |
Neogenomics Inc
|
223,846 | $3,265,913 | |
| 4 | VCYT |
Veracyte, Inc.
|
52,337 | $3,073,752 | |
| 5 | DGX |
Quest Diagnostics Inc
|
4,281 | $907,357 | |
| 6 | CSTL |
Castle Biosciences Inc
|
31,748 | $757,189 | |
| 7 | GRAL |
GRAIL, Inc.
This page
|
8,696 | $593,675 | |
| 8 | MYGN |
Myriad Genetics Inc
|
97,375 | $556,011 |
All Filings in GRAL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $593,675 | 8,696 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||